TATSUO ICHINOHE

Last Updated :2020/11/02

Affiliations, Positions
Research Institute for Radiation Biology and Medicine, Professor
E-mail
nohehiroshima-u.ac.jp
Self-introduction
Clinical Hematology, Hematopoietic Cell Transplantation

Basic Information

Academic Degrees

  • Doctor of Philosophy, Kyoto University

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Hematology

Affiliated Academic Societies

  • Japanese Society of Internal Medicine
  • Japanese Society of Chemotherapy, 2013
  • Japanese Society for Laboratory Medicine
  • Japanese Association of Germfree Life and Gnotobiology
  • Japanese Society for Histocompatibility and Immunogenetics
  • Japanese Society of Medical Oncology
  • Japanese Society for Hematology
  • Japanese Society of Transfusion Medicine and Cell Therapy
  • Japan Society for Hematopoietic Cell Transplantation, 1997
  • American Society of Hematology, 2003

Educational Activity

Course in Charge

  1. 2020, Undergraduate Education, Year, Clinical diagnosis and treatment II
  2. 2020, Undergraduate Education, Year, Systemic Disease Control
  3. 2020, Undergraduate Education, Intensive, Practice for medical research
  4. 2020, Undergraduate Education, First Semester, Internal Medicine Ⅱ
  5. 2020, Graduate Education (Doctoral Program) , First Semester, Integrated radiation medical science
  6. 2020, Graduate Education (Doctoral Program) , First Semester, Integrated radiation medical science
  7. 2020, Graduate Education (Doctoral Program) , First Semester, Integrated radiation medical science
  8. 2020, Graduate Education (Doctoral Program) , First Semester, Integrated radiation medical science
  9. 2020, Graduate Education (Doctoral Program) , First Semester, Advanced seminar on Hematology and Oncology
  10. 2020, Graduate Education (Doctoral Program) , Second Semester, Advanced seminar on Hematology and Oncology
  11. 2020, Graduate Education (Doctoral Program) , First Semester, Advanced research on Hematology and Oncology
  12. 2020, Graduate Education (Doctoral Program) , Second Semester, Advanced research on Hematology and Oncology
  13. 2020, Graduate Education (Master's Program) , Second Semester, General Clinical Medicine and Dentistry
  14. 2020, Graduate Education (Doctoral Program) , 1Term, Integrated Radiation Medical Science
  15. 2020, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Hematology and Oncology
  16. 2020, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Hematology and Oncology
  17. 2020, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Hematology and Oncology
  18. 2020, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Hematology and Oncology
  19. 2020, Graduate Education (Doctoral Program) , 2Term, Trends of Genome Editing in Medical Science

Research Activities

Academic Papers

  1. Impact of Homozygous Conserved Extended HLA Haplotype on Single Cord Blood Transplantation: Lessons for Induced Pluripotent Stem Cell Banking and Transplantation in Allogeneic Settings, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(1), 132-138, 202001
  2. Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan, INTERNATIONAL JOURNAL OF HEMATOLOGY, 111(1), 93-102, 202001
  3. Increased Relapse Risk of Acute Lymphoid Leukemia in Homozygous HLA-C1 Patients after HLA-Matched Allogeneic Transplantation: A Japanese National Registry Study, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), 431-437, 202003
  4. Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), 445-450, 202003
  5. Conditioning Intensity for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Poor-Prognosis Cytogenetics in First Complete Remission, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), 463-471, 202003
  6. Effects of Haplotype Matching on Outcomes after Adult Single-Cord Blood Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), 509-518, 202003
  7. Impact of HLA Allele Mismatch at HLA-A, -B, -C, and-DRB1 in Single Cord Blood Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(3), 519-528, 202003
  8. Impact of pretransplant donor-specific anti-HLA antibodies on cord blood transplantation on behalf of the Transplant Complications Working Group of Japan Society for Hematopoietic Cell Transplantation, BONE MARROW TRANSPLANTATION, 55(4), 722-728, 202004
  9. Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study, LEUKEMIA, 34(1), 128-137, 202001
  10. Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab, HEMATOLOGICAL ONCOLOGY, 38(2), 146-152, 202004
  11. Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 Dysfunction, CLINICAL CANCER RESEARCH, 26(8), 2065-2079, 202004
  12. Influence of HLA 1-3-locus mismatch and antithymocyte globulin administration in unrelated bone marrow transplantation, ANNALS OF HEMATOLOGY, 99(5), 1099-1110, 202005
  13. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(4), 718-722, 202004
  14. Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy, INTERNATIONAL JOURNAL OF HEMATOLOGY, 111(6), 897-902, 202006
  15. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century, ANNALS OF HEMATOLOGY, 99(6), 1351-1360, 202006
  16. Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI, PLOS ONE, 15(2), 20200227
  17. Outcome of stem cell transplantation for Waldenstrom's macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group, ANNALS OF HEMATOLOGY, 99(7), 1635-1642, 202007
  18. Pomalidomide-associated progressive multifocal leukoencephalopathy in multiple myeloma: cortical susceptibility-weighted imaging hypointense findings prior to clinical deterioration, JOURNAL OF NEUROVIROLOGY, 26(3), 452-455, 202006
  19. Stage-Specific Effects of Ionizing Radiation during Early Development, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 21(11), 202006
  20. Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype, BONE MARROW TRANSPLANTATION, 55(7), 1337-1346, 202007
  21. Impact of graft-versus-host disease and graft-versus-leukemia effect based on minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia, BRITISH JOURNAL OF HAEMATOLOGY, 190(1), 84-92, 202007
  22. Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with Allogeneic Stem Cell Transplantation in Japan, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26(8), 1543-1551, 202008
  23. Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors, BLOOD ADVANCES, 3(2), 105-115, 20190122
  24. High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation, BLOOD ADVANCES, 3(3), 397-405, 20190212
  25. The outcome and characteristics of patients with relapsed adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation, HEMATOLOGICAL ONCOLOGY, 37(1), 54-61, 201902
  26. Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades, BONE MARROW TRANSPLANTATION, 54(4), 578-586, 201904
  27. Hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma, INTERNATIONAL JOURNAL OF HEMATOLOGY, 109(4), 483-490, 201904
  28. Comparison of HLA Allele Mismatch and Antigen Mismatch in Unrelated Bone Marrow Transplantation in Patients with Leukemia, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(3), 436-442, 201903
  29. Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(3), 474-479, 201903
  30. HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome, HAEMATOLOGICA, 104(5), 1055-1061, 20190430
  31. Increased opportunity for prolonged survival after allogeneic hematopoietic stem cell transplantation in patients aged 60-69years with myelodysplastic syndrome, ANNALS OF HEMATOLOGY, 98(6), 1367-1381, 201906
  32. Cellular responses to ionizing radiation change quickly over time during early development in zebrafish, CELL BIOLOGY INTERNATIONAL, 43(5), 516-527, 201905
  33. Short-term clinical outcomes after HLA 1-locus mismatched uPBSCT are similar to that after HLA-matched uPBSCT and uBMT, INTERNATIONAL JOURNAL OF HEMATOLOGY, 109(6), 684-693, 201906
  34. Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with hepatitis-associated aplastic anemia, INTERNATIONAL JOURNAL OF HEMATOLOGY, 109(6), 711-717, 201906
  35. High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma: Data From the Japan Society for Hematopoietic Cell Transplantation Registry, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(5), 899-905, 201905
  36. Successful Treatment of Acute Chest Syndrome with Manual Exchange Transfusion in a Patient with Sickle Beta(+)-thalassemia, INTERNAL MEDICINE, 58(11), 1629-1634, 2019
  37. BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient, BLOOD ADVANCES, 3(11), 1750-1760, 20190611
  38. Outcomes of second allogeneic haematopoietic stem cell transplantation in patients with relapse of myelodysplastic syndrome, BRITISH JOURNAL OF HAEMATOLOGY, 186(1), 86-90, 201907
  39. Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning, LEUKEMIA & LYMPHOMA, 60(6), 1493-1502, 20190512
  40. Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation, BONE MARROW TRANSPLANTATION, 54(7), 1004-1012, 201907
  41. Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 25(7), 1441-1449, 201907
  42. ★, Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations, STEM CELLS, 36(3), 434-445, 201803
  43. Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma, INTERNATIONAL JOURNAL OF HEMATOLOGY, 107(4), 460-467, 201804
  44. Myeloma Cells Are Activated in Bone Marrow Microenvironment by the CD180/MD-1 Complex, Which Senses Lipopolysaccharide, CANCER RESEARCH, 78(7), 1766-1778, 20180401
  45. ★, Next-Generation Immune Repertoire Sequencing as a Clue to Elucidate the Landscape of Immune Modulation by Host-Gut Microbiome Interactions, FRONTIERS IN IMMUNOLOGY, 9, 20180403
  46. Impact of a Low CD34(+) Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(4), 708-716, 201804
  47. Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(4), 717-725, 201804
  48. Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(4), 832-839, 201804
  49. Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(4), 840-848, 201804
  50. Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma, ANNALS OF HEMATOLOGY, 97(8), 1445-1452, 201808
  51. Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(6), 1180-1186, 201806
  52. Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT), BRITISH JOURNAL OF HAEMATOLOGY, 182(2), 245-250, 201807
  53. Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation, BLOOD ADVANCES, 2(15), 1901-1913, 20180814
  54. Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(8), 1596-1601, 201808
  55. Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT), ANNALS OF HEMATOLOGY, 97(11), 2173-2183, 201811
  56. Suppression effect on IFN-gamma of adipose tissue-derived mesenchymal stem cells isolated from beta 2-microglobulin-deficient mice, EXPERIMENTAL AND THERAPEUTIC MEDICINE, 16(5), 4277-4282, 201811
  57. Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan, LEUKEMIA RESEARCH, 75, 50-57, 201812
  58. Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 24(10), 2139-2144, 201810
  59. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report, CLINICAL NEPHROLOGY, 90(3), 232-236, 201809
  60. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23(1), 75-80, 201701
  61. Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia, ANNALS OF HEMATOLOGY, 96(2), 289-297, 201702
  62. Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23(2), 300-309, 201702
  63. Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation, AMERICAN JOURNAL OF HEMATOLOGY, 92(2), 171-178, 201702
  64. Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8, ANNALS OF HEMATOLOGY, 96(3), 469-478, 201703
  65. Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide, LEUKEMIA & LYMPHOMA, 58(5), 1061-1067, 2017
  66. Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation, LEUKEMIA, 31(3), 663-668, 201703
  67. Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT, BONE MARROW TRANSPLANTATION, 52(2), 252-257, 201702
  68. Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105(3), 369-376, 201703
  69. Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil, BONE MARROW TRANSPLANTATION, 52(3), 423-430, 201703
  70. A phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database, BONE MARROW TRANSPLANTATION, 52(4), 574-579, 201704
  71. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105(5), 587-597, 201705
  72. Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation, INTERNATIONAL JOURNAL OF HEMATOLOGY, 105(6), 805-811, 201706
  73. Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities, ONCOLOGY REPORTS, 38(1), 449-455, 201707
  74. ★, Highly functional T-cell receptor repertoires are abundant in stem memory T cells and highly shared among individuals, SCIENTIFIC REPORTS, 7, 20170616
  75. Isolation of mesenchymal stromal/stem cells from cryopreserved umbilical cord blood cells, JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 57(1), 1-8, 2017
  76. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Abnormalities of the Short Arm of Chromosome 17, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23(8), 1398-1404, 201708
  77. Clinical impact of pretransplant use of multiple tyrosine kinase inhibitors on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia, AMERICAN JOURNAL OF HEMATOLOGY, 92(9), 902-908, 201709
  78. GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia, BONE MARROW TRANSPLANTATION, 52(9), 1261-1267, 201709
  79. Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation, BONE MARROW TRANSPLANTATION, 52(10), 1390-1398, 201710
  80. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation, BONE MARROW TRANSPLANTATION, 52(11), 1563-1570, 201711
  81. Comparison of Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Allogeneic Transplantation Recipients 50 Years or Older, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23(12), 2079-2087, 201712
  82. Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders, INFLAMMATION AND REGENERATION, 37, 2017
  83. Effects of acute exposure to low-dose radiation on the characteristics of human bone marrow mesenchymal stromal/stem cells, INFLAMMATION AND REGENERATION, 37, 2017
  84. Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma, BONE MARROW TRANSPLANTATION, 51(2), 205-211, 201602
  85. Early osteoinductive human bone marrow mesenchymal stromal/stem cells support an enhanced hematopoietic cell expansion with altered chemotaxis- and adhesion-related gene expression profiles, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 469(4), 823-829, 20160122
  86. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes, BONE MARROW TRANSPLANTATION, 51(3), 403-409, 201603
  87. Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22(5), 932-940, 201605
  88. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older, AMERICAN JOURNAL OF HEMATOLOGY, 91(5), E284-E292, 201605
  89. A multicenter phase 2 study of pomalidomide plus dexamethasone in patients with relapsed and refractory multiple myeloma: the Japanese MM-011 trial, EXPERIMENTAL HEMATOLGY & ONCOLOGY, 5, 20160418
  90. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia, HAEMATOLOGICA, 101(5), 644-652, 201605
  91. Maintenance of the functional integrity of mouse hematopoiesis by EED and promotion of leukemogenesis by EED haploinsufficiency, SCIENTIFIC REPORTS, 6, 20160719
  92. ★, Biological implications of somatic DDX41 p.625H mutation in acute myeloid leukemia, EXPERIMENTAL HEMATOLOGY, 44(8), 745-754, 2016
  93. Famotidine-induced reactive plasmacytosis and generalized lymphadenopathy: a case report and review of the literature, INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 9(7), 7680-7685, 2016
  94. Efficacy and safety of rituximab in Japanese patients with acquired thrombotic thrombocytopenic purpura refractory to conventional therapy, INTERNATIONAL JOURNAL OF HEMATOLOGY, 104(2), 228-235, 201608
  95. Tandem autologous versus autologous/allogeneic transplantation for multiple myeloma: propensity score analysis, LEUKEMIA & LYMPHOMA, 57(9), 2077-2083, 201609
  96. Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22(11), 2031-2037, 201611
  97. Allogeneic Hematopoietic Cell Transplantation for Leukemic Transformation Preceded by Philadelphia Chromosome Negative Myeloproliferative Neoplasms: A Nationwide Survey by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22(12), 2208-2213, 201612
  98. All-trans retinoic acid enhances cytotoxic effect of T cells with an anti-CD38 chimeric antigen receptor in acute myeloid leukemia, CLINICAL & TRANSLATIONAL IMMUNOLOGY, 5, 201612
  99. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling, INTERNATIONAL JOURNAL OF HEMATOLOGY, 103(4), 461-468, 201604
  100. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups, HAEMATOLOGICA, 101(12), 1592-1602, 20161130
  101. Impact of HLA Mismatch Direction on the Outcome of Unrelated Bone Marrow Transplantation: A Retrospective Analysis from the Japan Society for Hematopoietic Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 21(2), 305-311, 201502
  102. Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation, BONE MARROW TRANSPLANTATION, 50(4), 559-565, 201504
  103. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation, BLOOD, 125(7), 1189-1197, 20150212
  104. A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch, AMERICAN JOURNAL OF HEMATOLOGY, 90(7), 618-623, 201507
  105. Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm, BLOOD, 125(23), 3559-3562, 20150604
  106. Isolation of mesenchymal stromal/stem cells from small-volume umbilical cord blood units that do not qualify for the banking system, INTERNATIONAL JOURNAL OF HEMATOLOGY, 102(2), 218-229, 201508
  107. Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy, JOURNAL OF HEMATOLOGY & ONCOLOGY, 8, 20150904
  108. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic C, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 21(11), 2008-2016, 201511
  109. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient, HEPATOLOGY RESEARCH, 45(10), E150-E155, OCT 2015
  110. The Impact of HLA Mismatch Only in the Host-Versus-Graft Direction on the Outcome of Related Hematopoietic Stem Cell Transplantation for Patients with HLA-Homozygous Haplotypes: A Retrospective Analysis of the JSHCT HLA Working Group Study, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 21(2), S159-S160, 2015
  111. Kanda Y, Kanda J, Atsuta Y, Fuji S, Maeda Y, Ichinohe T, Takanashi M, Ohashi K, Fukuda T, Miyamura K, Mori T, Sao H, Kobayashi N, Iwato K, Sawada A, Mori S; HLA working group of the Japan Society for Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2014 Jan 10 EPub ahead of print. , 20140101
  112. A Novel Frameshift Mutation in Exon 4 Causing a Deficiency of High-molecular-weight Kininogen in a Patient with Splenic Infarction, INTERNAL MEDICINE, 53(3), 253-257, 2014
  113. CCAAT/Enhancer-Binding Protein beta Expressed by Bone Marrow Mesenchymal Stromal Cells Regulates Early B-Cell Lymphopoiesis, STEM CELLS, 32(3), 730-740, 201403
  114. Changes in the Clinical Impact of High-Risk Human Leukocyte Antigen Allele Mismatch Combinations on the Outcome of Unrelated Bone Marrow Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(4), 526-535, 201404
  115. Parathyroid Hormone Enhances Hematopoietic Expansion Via Upregulation of Cadherin-11 in Bone Marrow Mesenchymal Stromal Cells, STEM CELLS, 32(8), 2245-2255, 2014
  116. Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT, BONE MARROW TRANSPLANTATION, 49(9), 1187-1192, 201409
  117. Systemic approaches to organ-specific complications after allogeneic hematopoietic cell transplantation, Rinsho Ketsueki, 55(10), 2125-2135, 2014
  118. Impact of Conditioning Intensity with or without Total Body Irradiation on Acute Graft-Versus-Host Disease and Clinical Outcomes, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(2), S275-S276, 2014
  119. Therapeutic management in cardiac lymphoma, LEUKEMIA & LYMPHOMA, 55(5), 1215-1217, 2014
  120. Concurrent administration of darbepoetin alfa, cyclosporine A, and prednisolone is useful for T cell large granular lymphocyte leukemia associated with myelodysplastic syndrome complicated by Coombs-negative hemolytic anemia, ANNALS OF HEMATOLOGY, 93(11), 1937-1939, 2014
  121. Effects of Irradiation on the Functional Characteristics of Human Bone Marrow Mesenchymal Stromal/Stem Cells, BLOOD, 124(21), 2014
  122. Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia Transformed from Ph-Negative Myeloproliferative Neoplasm: A Study from the Adult AML Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT), BLOOD, 124(21), 2014
  123. Long-Term Survival with High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Registry Study from the Japan Society for Hematopoietic Cell Transplantation, BLOOD, 124(21), 2014
  124. Impact of Low-Dose TBI on Outcome of Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation from HLA Identical Sibling for Acute Myeloid Leukemia, BLOOD, 124(21), 2014
  125. on behalf of the Donor/Source Working Group and HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.Unrelated cord blood transplantation vs. related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction., Leukemia, 27(2), 286-294, 20130201
  126. HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation., Biol Blood Marrow Transplant, 19(2), 247-254, 20130201
  127. Souichiro Sakamoto, Hiroshi Kawabata, Junya Kanda, Tatsuki Uchiyama, Chisaki Mizumoto, Tadakazu Kondo, Kouhei Yamashita, Tatsuo Ichinohe, Takayuki Ishikawa, Norimitsu Kadowaki, Akifumi Takaori-Kondo. Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2013 Jan; 97(1):109-16., 20130101
  128. Makoto Hirokawa, Takahiro Fukuda, Hideki Akiyama, Michihiro Hidaka, Tatsuo Ichinohe, Koji Iwato, Heiwa Kanamori, Makoto Murata, Toru Sakura, Masahiro Imamura, Soichi Adachi, Ritsuro Suzuki, Yasuo Morishima and Hisashi Sakamaki, for The PRCA Collaborative Study Group. Efficacy and long-term outcome of treatment for pure red cell aplasia (PRCA) following allogeneic hematopoietic stem cell transplantation (HSCT) from major ABO-incompatible donors. Biol Blood Marrow Transplant. 2013 Jul;19(7):1026-32. [EPub 2013 Apr 10], 20130701
  129. Yoshinobu Kanda, Junya Kanda, Yoshiko Atsuta, Yoshinobu Maeda, Tatsuo Ichinohe, Kazuteru Ohashi, Takahiro Fukuda, Koichi Miyamura, Hiromitsu Iida, Takehiko Mori, Koji Iwato, Tetsuya Eto, Keisei Kawa, Satoshi Morita, Yasuo Morishima. Impact of a single HLA allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation. Br J Haematol. 2013 May;161(4):566-77.[EPub 2013 Mar 4], 20130501
  130. Miura Y, Yoshioka S, Yao H, Takaori-Kondo A, Maekawa T, Ichinohe T. Chimerism of bone marrow mesenchymal stem/stromal cells in allogneic hematopoietic cell transplantation: is it clinically relevant? Chimerism 2013 Jul;4(3):78-83., 20130701
  131. Yoshihara M, Itamura H, Fukushima N, Itoh M, Furukawa K, Nagatomo D, Kamachi K, Kitamura H, Shindo T, Kubota Y, Sueoka E, Morita S, Ichinohe T, Kimura S. Therapeutic management in cardiac lymphoma. Leuk Lymphoma. 2013 Sep 3 Epub ahead of print., 20130901
  132. Yoshioka S, Miura Y, Yao H, Satake S, Hayashi Y, Tamura A, HIshita T, Ichinohe T, Hirai H, Takaori-Kondo A, Maekawa T. Stem Cells. 2013 Oct 1 EPub ahead of print., 20131001
  133. Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation, INTERNATIONAL JOURNAL OF HEMATOLOGY, 97(1), 109-116, 2013
  134. Impact of the Direction of HLA Mismatch on Transplantation Outcomes in Single Unrelated Cord Blood Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(2), 247-254, 2013
  135. Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation, BRITISH JOURNAL OF HAEMATOLOGY, 161(4), 566-577, 2013
  136. Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(7), 1026-1032, 2013
  137. ★, Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study, BLOOD, 119(9), 2141-2148, 2012
  138. Hidekazu Itamura, Noriyasu Fukushima, Seiji Kondo, Chisako Urata, Mariko Yoshimura, Masako Yokoo, Masaru Ide, Takashi Hisatomi, Yasushi Kubota, Eisaburo Sueoka, Tatsuo Ichinohe, Shinya Kimura. Successful Reduced-intensity umbilical cord blood transplantation for fulminant hemophagocytic syndrome in an adult with pre-existing rheumatoid arthritis and autoimmune hemolytic anemia.Leuk Lymphoma. 2012 Nov;53(11):2307-2309 [EPub 2012 Apr19], 20121101
  139. Takeshi Ito, Kenichiro Akagi, Kentaro Akagi, Tadakazu Kondo, Hiroshi Kawabata, Tatsuo Ichinohe, Akifumi Takaori-Kondo. Splenic irradiation as a component of a reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis with massive splenomegaly. Tohoku J Exp Med. 2012; 228(4):295-299. , 20120401
  140. Successful reduced-intensity umbilical cord blood transplant for fulminant hemophagocytic syndrome in an adult with pre-existing rheumatoid arthritis and autoimmune hemolytic anemia, LEUKEMIA & LYMPHOMA, 53(11), 2307-2309, 2012
  141. Splenic Irradiation as a Component of a Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Myelofibrosis with Massive Splenomegaly, TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 228(4), 295-299, 2012
  142. Combination Effects of Nilotinib and Zoledronic Acid On Chronic Myeloid Leukemia Are Canceled in the Co-Culture System Which Mimic the Bone Marrow Microenvironment, BLOOD, 120(21), 2012
  143. Expression of C/EBP beta in Bone Marrow Mesenchymal Stem Cells Is Mandatory for Early-Stage B Cell Lymphopoiesis, BLOOD, 120(21), 2012
  144. Kanda J, Mizumoto C, Ichinohe T, Kawabata H, Saito T, Yamashita K, Kondo T, Takakura S, Ichiyama S, Uchiyama T, Ishikawa T. Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2011Feb 2; 46(2):208-216. 2010 May 3. [EPub ahead of print.], 20110201
  145. Takashi Saito, Tatsuo Ichinohe, Junya Kanda, Miki Nagao, Shunji Takakura, Yutaka Ito, Yoshitsugu Iinuma, Kouhei Yamashita, Tadakazu Kondo, Takayuki Ishikawa, Takashi Uchiyama, Satoshi Ichiyama. Historical cohort study of the efficacy and safety of piperacillin/tazobactam versus fourth-generation cephalosporins for empirical treatment of febrile neutropenia in patients with hematological malignancies. Int J Clin Med. 2011; 2(1):18-22., 20110101
  146. Takayuki Sato, Tatsuo Ichinohe, Junya Kanda, Kouhei Yamashita, Tadakazu Kondo, Takauki Ishikawa, Takashi Uchiyama, Akifumi Takaori-Kondo. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria. Int J Hematol. 2011;93(4):532-541., 20110401
  147. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria, INTERNATIONAL JOURNAL OF HEMATOLOGY, 93(4), 532-541, 2011
  148. Yoshihide Ueda, Hiroyuki Marusawa, Tatsuo Ichinohe, Norimitsu Kadowaki, Takashi Uchiyama, Tsutomu Chiba. Effective treatment for de novo hepatitis B with nucleoside analogue in patients with hematological malignancies. Am J Hematol. 2009; 84(5): 315-316., 20101201
  149. Junya Kanda, Keitaro Matsuo, Takeshi Suzuki, Satoyo Hosono, Hidemi Ito, Tatsuo Ichinohe, Masao Seto, Yasuo Morishima, Kazuo Tajima, Hideo Tanaka. Association between obesity and the risk of malignant lymphoma in Japanese: A case-cotrol study. Int J Cancer. 2010; 126(10):2416-2425. , 20100501
  150. Kosuke Ueda, Matsui Hiroyuki, Tomohiro Watanabe, Junya Seki, Tatsuo Ichinohe, Yoshihisa Tsuji, Kayoko Matsumura, Yugo Sawai, Hiroshi Ido, Yoshihide Ueda, Tsutomu Chiba. Spontaneous rupture of liver plasmacytoma mimicking hepatocellular carcinoma. Intern Med. 2010; 49 (7):653-657., 20100801
  151. Koji Nagafuji, Keitaro Matsuo, Takanori Teshima, Shin-ichi Mori, Hisahi Sakamaki, Michihiro Hidaka, Hiroyasu Ogawa, Yoshihisa Kodera, Yoshinobu Kanda, Atsuo Maruta, Takehiko Mori, Fumiaki Yoshiba, Tatsuo Ichinohe, Masanobu Kasai, Yoshifusa Takatsuka, Kohmei Kubo, Hiroshi Sao, Yoshiko Atsuta, Ritsuro Suzuki, Takashi Yoshida, Masahiro Tsuchida, Mine Harada. Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry. Int J Hematol 2010; 91(5):855-864. EPub 2010 May 14., INTERNATIONAL JOURNAL OF HEMATOLOGY, 91(5), 855-864, 20100601
  152. ★, Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study, BLOOD, 116(8), 1369-1376, 2010
  153. Tatsuo Ichinohe. Long-term fetal-maternal microchimerism revisited: microchimeirsm and tolerance in hematopoietic stem cell transplantation. Chimerism. 2010; 1(1): 39-43., 20100701
  154. Kazunari Aoki, Shinichi Kotani, Tatsuo Ichinohe, Tadakazu Kondo, Takayuki Ishikawa. Acute renal failure associated with systemic polyoma BK virus activation in a patient with periheral T-cell lymphoma. Int J Hematol. 2010;92(4):638-641., 20101101
  155. Spontaneous Rupture of Liver Plasmacytoma Mimicking Hepatocellular Carcinoma, INTERNAL MEDICINE, 49(7), 653-657, 2010
  156. Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study, INTERNATIONAL JOURNAL OF CANCER, 126(10), 2416-2425, 2010
  157. Acute renal failure associated with systemic polyoma BK virus activation in a patient with peripheral T-cell lymphoma, INTERNATIONAL JOURNAL OF HEMATOLOGY, 92(4), 638-641, 2010
  158. Impact of Serum Ferritin Levels on the Incidence of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation., BLOOD, 116(21), 535-535, 2010
  159. Junya Kanda, Tatsuo Ichinohe, Keitaro Matsuo, Richard J. Benjamin, Thomas R. Klumpp, Primoz Rozman, Neil Blumberg, Jayesh Mehta, Sang-Kyun Sohn, Takashi Uchiyama. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: Individual patient data-based meta-analysis of cohort studies. Transfusion. 2009; 49(4):624-635. EPub 2009 Jan 2., 20090101
  160. Kazutoshi Aoyama, Motoko Koyama, Ken-ichi Matsuoka, Daigo Hashimoto, Tatsuo Ichinohe, Mine Harada, Koichi Akashi, Mitsune Tanimoto, Takanori Teshima. Improved outcome of allogeneic bone marrow transplantation due to breast-feeding-induced tolerance to maternal antigens. Blood. 2009; 113(8): 1829-1833. EPub 2009 Jan 5., 20090101
  161. Kanda J, Ichinohe T, Shimazaki C, Hamaguchi M, Watanabe A, Ishida H, Yoshihara T, Morimoto A, Uoshima N, Adachi S, Inukai T, Sawada A, Oka K, Itoh M, Hino M, Maruya E, Saji H, Uchiyama T, Kodera Y. Long-term survival after HLA-haploidentical stem cell transplantation from non-inherited maternal antigen-mismatched family donors: impact of chronic graft-versus-host disease. Bone Marrow Transplant. 2009; 44(5): 327-329. EPub 2009 Feb 16., 20090101
  162. Takashi Saito, Akifumi Takaori-Kondo, Masaharu Tashima, Kouhei Yamashita, Yoshitsugu Iinuma , Shunji Takakura, Miki Nagao, Tatsuo Ichinohe, Takayuki Ishikawa, Takashi Uchiyama, Satoshi Ichiyama. Successful treatment with intravenous colistin for sinusitis, orbital cellulites, and pneumonia caused by multidrug-resistant metallo-beta-lactamase- producing Pseudomonas aeruginosa in a patient with acute myeloid leukemia.Int J Hematol. 2009; 89(5): 689-692. EPub 2009 Mar24, 20090301
  163. Chisato Mizumoto, Junya Kanda, Tatsuo Ichinohe, Takayuki Ishikawa, Masashi Matsui, Norimitsu Kadowaki, Tadakazu Kondo, Kazunori Imada, Masakatsu Hishizawa, Hiroshi Kawabata, Momoko Nishikori, Kouhei Yamashita, Akifumi Takaori-Kondo, Toshiyuki Hori, Takashi Uchiyama. Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning. Int J Hematol. 2009; 89(4): 538-545. EPub 2009 Apr 11., 20090401
  164. Junya Kanda, Chisaki Mizumoto, Hiroshi Kawabata, Tatsuo Ichinohe, Hideyuki Tsuchida, Naohisa Tomosugi, Keitaro Matsuo, Kouhei Yamashita, Tadakazu Kondo, Takayuki Ishikawa, Takashi Uchiyama. Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009; 15(8):956-962. , 20090401
  165. Ryo Yamamoto, Momoko Nishikori, Masahru Tashima, Tomomi Sakai, Tatsuo Ichinohe, Akifumi Takaori-Kondo, Katsuyuki Ohmori, Takashi Uchiyama. B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma. Cancer Sci. 2009; 100(11): 2093-2100. EPub 2009 Aug 1., 20090801
  166. Junya Kanda, Keitaro Matsuo, Tadakazu Kawase, Takeshi Suzuki, Tatsuo Ichinohe, Masao Seto, Yasuo Morishima, Kazuo Tajima, Tanaka Hideo. Association of alcohol intake and smoking with malignant lymphoma risk in Japanese: A hospital-based case-control study at Aichi Cancer Center. Cancer Epidemiol Biomarkers Prev. 2009; 18(9): 2436-2441. EPub 2009 Sep 1., 20090901
  167. Kanda J, Ichinohe T, Saito T, Yamashita K, Kondo T, Ishikawa T, Ichiyama S, Uchiyama T. Impact of discontinuing fluoroquinolone prophylaxis after allogeneic marrow or peripheral blood SCT with myeloablative conditioning. Bone Marrow Transplant. 2010; 45(8):1369-1371. EPub 2009 Dec 7. , 20091201
  168. Improved outcome of allogeneic bone marrow transplantation due to breastfeeding-induced tolerance to maternal antigens, BLOOD, 113(8), 1829-1833, 2009
  169. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies, TRANSFUSION, 49(4), 624-635, 2009
  170. Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning, INTERNATIONAL JOURNAL OF HEMATOLOGY, 89(4), 538-545, 2009
  171. Successful treatment with intravenous colistin for sinusitis, orbital cellulites, and pneumonia caused by multidrug-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in a patient with acute myeloid leukemia, INTERNATIONAL JOURNAL OF HEMATOLOGY, 89(5), 689-692, 2009
  172. Clinical Significance of Serum Hepcidin Levels on Early Infectious Complications in Allogeneic Hematopoietic Stem Cell Transplantation, BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 15(8), 956-962, 2009
  173. Association of Alcohol Intake and Smoking with Malignant Lymphoma Risk in Japanese: A Hospital-Based Case-Control Study at Aichi Cancer Center, CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 18(9), 2436-2441, 2009
  174. B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma, CANCER SCIENCE, 100(11), 2093-2100, 2009
  175. Clinical Significance of Severity and Subcategory of Chronic GVHD Evaluated by NIH Consensus Criteria, BLOOD, 114(22), 874-874, 2009
  176. Muramatsu H, Kimura S, Ichinohe T, Ashihara E, Ishikawa T, Maekawa T, Uchiyama T. Consulting clinic for related family donors in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008; 41(12):1073-1075. , 20080601
  177. Saito T, Yoshioka S, Iinuma Y, Takakura S, Fujihara N, Ichinohe T, Ishikawa T, Uchiyama T, Ichiyama S. Effects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology-oncology unit. Eur J Clin Microbiol Infect Dis. 2008; 27(3):219-216., 20080301
  178. Toshio Kitawaki, Norimitsu Kadowaki, Tadakazu Kondo, Takayuki Ishikawa, Tatsuo Ichinohe, Satoshi Teramukai, Masanori Fukushima, Yasunari Kasai, Taira Maekawa, Takashi Uchiyama. Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia. Am J Hematol. 2008; 83(4): 315-317., 20080401
  179. Clinical Significance of Serum Hepcidin-25 Levels on Early Treatment-Related Complications after Hematopoietic Stem Cell Transplantation, BLOOD, 112(11), 424-424, 2008
  180. Reactivation of Human Herpes Virus 6 (HHV6) during Hematopoietic Stem Cell Transplantation: Risk Factor Analysis of HHV6 Encephalitis and Survival, BLOOD, 112(11), 775-775, 2008
  181. Kazue Arimoto, Norimitsu Kadowaki, Takayuki Ishikawa, Tatsuo Ichinohe, Takashi Uchiyama. FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation. Int J Hematol. 2007; 85(2):154-162., 20070201
  182. Chonabayashi K, Kondo T, Tanaka Y, Ichinohe T, Ishikawa T, Uchiyama T. Sustained complete remission of refractory enteropathy-type T-cell lymphoma following reduced-intensity unrelated cord blood transplantation. Bone Marrow Transplant 2007; 40(9): 905-906., 20071101
  183. Sasaki K, Yamashita K, Miyoshi T, Furukawa Y, Kimura T, Kita T, Ichinohe T, Ishikawa T, Sasada M, Uchiyama T. Analysis of serum angiogenic factors in a young multiple myeloma patient with high-output cardiac failure. Int J Hematol. 2007; 86(1): 72-76., 20070701
  184. Ryo Yamamoto, Akifumi Takaori-Kondo, Junya Kanda, Kazunori Imada, Tatsuo Ichinohe, Takayuki Ishikawa, Katsuyuki Ohmori, Takashi Uchiyama. Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.Bone Marrow Transplant. 2008; 41(6):591-593. EPub 2007 Dec10., 20071201
  185. FOXP3 Expression in Peripheral Blood Rapidly Recovers and Lacks Correlation with the Occurrence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation, Int J Hematol, 85(2), 154-162, 20070215
  186. Reversible cardiomyopathy associated with multicentric Castleman disease: Successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody, INTERNATIONAL JOURNAL OF HEMATOLOGY, 85(3), 207-211, 2007
  187. Analysis of serum angiogenic factors in a young multiple myeloma patient with high-output cardiac failure, INTERNATIONAL JOURNAL OF HEMATOLOGY, 86(1), 72-76, 2007
  188. Breast-feeding mediates feto-maternal tolerance and improves outcome of allogeneic bone marrow transplantation, BLOOD, 110(11), 644A-644A, 2007
  189. Monitoring of serum hepcidin-25 in multicentric Castleman's disease patients treated with tocilizumab, an anti-interleukin-6 receptor antibody, BLOOD, 110(11), 1077A-1077A, 2007
  190. Similar background of graft-versus-host disease (GVHD) following allogeneic blood and marrow transplantation (Tx) in Korean and Japanese populations allows a uniform foundation to perform large-scale clinical studies in the region, BLOOD, 110(11), 330B-330B, 2007
  191. Long-term survival after HLA-haploidentical stem cell transplantation, from non-inherited maternal antigen-mismatched family donors: Impact of chronic graft-versus-host disease, BLOOD, 110(11), 349B-349B, 2007
  192. Ken-ichi Matsuoka, Tatsuo Ichinohe, Daigo Hashimoto, Shoji Asakura, Mitsune Tanimoto, Takanori Teshima. Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4+CD25+ T-cell-dependent mechanism. Blood., 20060901
  193. Takanori Teshima, Ken-ichi Matsuoka, Tatsuo Ichinohe. Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation. Arch Immunol Ther Exp (Warsz). 2006; 54(3):165-172. EPub 2006 May 2., 20060501
  194. Sung-Won Kim, Tetsuya Tanimoto, Noriyuki Hirabayashi, Seiichi Goto, Masahiro Kami, Satoshi Yoshioka, Toshiki Uchida, Kenji Kishi, Yuji Tanaka, Akio Kohno, Masaharu Kasai, Masakazu Higuchi, Masanobu Kasai, Shin-ichiro Mori, Takahiro Fukuda, Koji Izutsu, Hiroshi Sao, Takayuki Ishikawa, Tatsuo Ichinohe, Kengo Takeuchi, Kinuko Tajima, Ryuji Tanosaki, Mine Harada, Shuichi Taniguchi, Kensei Tobinai, Tomomitsu Hotta, Yoichi Takaue. Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan. Blood. 2006; 108(1):382-389. EPub 2006 Mar 7., 20060601
  195. Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation, ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 54(3), 165-172, 2006
  196. Yoshihisa Kodera, Tetsuya Nishida, Tatsuo Ichinohe, Hiroh Saji. Human leukocyte antigen haploidentical hematopoietic stem cell transplantation: indications and tentative outcomes in Japan. Semin Hematol. 2005; 42(2):112-118., 20050401
  197. Tatsuo Ichinohe, Takanori Teshima, Ken-ichi Matsuoka, Etsuko Maruya, Hiroh Saji. Fetal-maternal microchimerism: impact on hematopoietic stem cell transplantation. Curr Opin Immunol. 2005; 17(5):546-552. , 20051001
  198. Kojima R, Kami M, Kanda Y, Kusumi E, Kishi Y, Tanaka Y, Yoshioka S, Morishima S, Fujisawa S, Mori SI, Kasai M, Hatanaka K, Tajima K, Kasai M, Mitani K, Ichinohe T, Hirai H, Taniguchi S, Sakamaki H, Harada M, Takaue Y. Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years. Bone Marrow Transplant. 2005; 36(8):667-674., 20051001
  199. Narimatsu H, Wake A, Miura Y, Tanaka H, Matsumura T, Takagi S, Kato D, Myojo T, Kusumi E, Masuoka K, Miyakoshi S, Morinaga S, Saji H, Ichinohe T, Taniguchi S. Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion. Bone Marrow Transplant. 2005; 36(6):555-556. , 20050901
  200. ★, Tatsuo Ichinohe, Takashi Uchiyama, Chihiro Shimazaki, Keitaro Matsuo, Shigehisa Tamaki, Masayuki Hino, Arata Watanabe, Motohiro Hamaguchi, Souichi Adachi, Hisashi Gondo, Nobuhiko Uoshima, Takao Yoshihara, Kazuo Hatanaka, Hiroshi Fujii, Keisei Kawa, Kazunobu Kawanishi, Koji Oka, Hideo Kimura, Mitsuru Itoh, Takeshi Inukai, Etsuko Maruya, Hiroh Saji, Yoshihisa Kodera. Feasibility of HLA-haploidentical hematopoietic stem-cell transplantation between non-inherited maternal antigen (NIMA)-mismatched family members linked with long-term feto-maternal microchimerism. Blood. 2004; 104(12):3821-3828. EPub 2004 Jul 27., BLOOD, 20041201
  201. Umeda K, Adachi S, Ishihara H, Higashi Y, Shiota M, Wananabe KI, Hishizawa M, Ichinohe T, Kitoh T, Maruya E, Saji H, Uchiyama T, Nakahata T. Successful T-cell-replete peripheral blood stem cell transplantation from HLA-haploidentical microchimeric mother to daughter with refractory acute lymphoblastic leukemia using reduced-intensity conditioning. Bone Marrow Transplant 2003; 31(11):1061-1063., 20030601
  202. Kitawaki T, Kadowaki N, Ishikawa T, Ichinohe T, Uchiyama T. Compromised recovery of natural interferon-alpha/beta-producing cells after allogeneic hematopoietic stem cell transplantation complicated by acute graft-versus-host-disease and glucocorticoid administration. Bone Marrow Transplant. 2003; 32(2):187-194., 20030701
  203. Ai Kotani, Atsushi Takahashi, Hikari Koga, Rinpei Morita, Hidenao Fukuyama, Tatsuo Ichinohe, Takyuki Ishikawa, Toshiyuki Hori, Takashi Uchiyama. Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40+CD4+ T cells. Eur J Haematol. 2002; 69(5-6):318-320. , 20021101
  204. Takashi Kobayashi, Shingo Yamamoto, Eijiro Nakamura, Toshiyuki Kamato, Yoshiyuki Kakehi, Osamu Ogawa, Noriyuki Ito, Takuo Fukuyama, Masakatsu Hishizawa, Tatsuo Ichinohe. Dose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: a case report. Jpn J Clin Oncol. 2002; 32(1):33-34. , 20020101
  205. Shigehisa Tamaki, Tatsuo Ichinohe, Keitaro Matsuo, Nobuyuki Hamajima, Noriyuki Hirabayashi, Hiroo Dohy: Superior survival of blood and marrow stem-cell recipients given maternal grafts over recipients given paternal grafts. Bone Marrow Transplant. 2001; 28(4):375-380. , 20010801
  206. Ai Kotani, Takayuki Ishikawa, Yumi Matsumura, Tatsuo Ichinohe, Hitoshi Ohno, Toshiyuki Hori, Takashi Uchiyama. Correlation of peripheral blood OX40+ T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation. Blood. 2001; 98(10):3162-3164. , 20011101
  207. C.Graham Knight, Laurence F. Morton, David J. Onley, Anthony R. Peachy, Tatsuo Ichinohe, Minoru Okuma, Richard W. Farndale, Michael J. Barnes. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet GPVI and mediates platelet activation by collagen. Cardiovasc Res. 1999; 41(2):450-457. , 19990201
  208. ★, Tatsuo Ichinohe, Hiroshi Takayama, Yasuharu Ezumi, Morio Arai, Naomasa Yamamoto, Hoyu Takahashi, Minoru Okuma: Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI. J Biol Chem. 1997; 272(1):63-68. , 272(1), 63-68, 19970101
  209. Takafumi Ishibashi, Tatsuo Ichinohe, Tateo Sugiyama, Hiroshi Takayama, Kouichi Chitani, Minoru Okuma. Functional significance of platelet membrane glycoprotein p62 (GP VI), a putative collagen receptor. Int J Hematol 1995; 62(2):107-115., 19950801
  210. ★, Tatsuo Ichinohe, Hiroshi Takayama, Yasuharu Ezumi, Shigeru Yanagi, Hirohei Yamamura, Minoru Okuma: Cyclic AMP-insensitive activation of c-Src and Syk protein-tyrosine kinases through platelet membrane glycoprotein VI. J Biol Chem. 1995; 270(47):28029-28036. , 19951101
  211. Yataro Yoshida, Tatsuo Ichinohe, Mayumi Dodo, Masaharu Noukawa, Akinori Maeda, Shigeru Oguma, Masao Tajima, Koukichi Yamamoto, Minoru Okuma. Successful bone marrow transplantation with rabbit anti-human thymocyte globulin in aplastic anemia. Report of a case previously treated with equine anti-human lymphocyte globulin.Int J Hematol. 1994; 60(1):79-83. , 19940101
  212. Involvement of GPIIb-IIIa on human platelets in phosphotyrosine-specific dephosphorylation., BIOCHEMICAL BIOPHYSICAL RESEARCH COMMUNICATION, 194(1), 472-477, 1993
  213. Potential of dendritic cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole limpet hemocyanin-pulsed, donor-derived dendritic cell vaccine for acute myeloid leukemia, AMERICAN JOURNAL OF HEMATOLOGY, 83(4), 315-317, 2008
  214. Immunomodulatory drugs (IMiDs), 72(6), 1130-1135, 201406
  215. T Cell Non-depleted Bone Marrow Transplantation for Primary Refractory Erythroleukemia Using a Partially HLA-mismatched Related Donor, Rinsho Ketsueki, 40(7), 581-586, 19990730
  216. Functional significance of platelet membrane glycoprotein p62 (GP VI), a putative collagen receptor, 62(2), 107-115, 199508
  217. Platelet Activation Through Membrane Glycoprotein VI, 7(3), 251-254, 19960601
  218. Current status of reduced-intensity stem cell transplantation;Survey in the Kinki area, 44(6), 407-413, 20030630
  219. Clinical significance of fetal-maternal immunological tolerance in HLA-mismatched allogeneic stem cell transplantation, Journal of germfree life and gnotobiology, 36(1), 24-27, 20060901
  220. Clinical significance of the "NIMA effect" in HLA-mismatched hematopoietic stem cell transplantation, 47(7), 618-625, 20060730
  221. Reappraisal of gastrointestinal decontamination as a practice in preventing infectious complications after hematopoietic stem-cell transplantation, Journal of germfree life and gnotobiology, 37(1), 18-22, 20070601
  222. Epstein-Barr virus-associated B cell lymphoproliferative disorder complicated in adult T-cell leukemia, Rinsho Ketsueki, 49(4), 263-269, 20080430
  223. Allogeneic hematopoietic stem cell transplantation from an HLA-haploidentical related donor based on feto-maternal tolerance, Journal of Okayama Medical Association, 120(1), 23-28, 20080501
  224. CONSULTING CLINIC FOR RELATED FAMILY DONORS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION, 56(1), 68-71, 20100225
  225. Myeloproliferative neoplasms (including chronic myeloid leukemia), 53(1), 59-70, 20120130
  226. MANAGEMENT OF TRANSFUSIONAL IRON OVERLOAD, 59(1), 73-78, 20130228
  227. Administration of Once-Daily Tacrolimus Extended-Release Formulation in Allogeneic Stem Cell Transplantation, Journal of Hematopoietic Cell Transplantation, 1(2), 59-65, 2012
  228. Long-term remission in patients with plasma cell myeloma after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation::A 10-year single-center experience, Journal of Hematopoietic Cell Transplantation, 2(1), 25-31, 2013
  229. Relationship between internal A-V fistula obstruction and plasma level of von Willebrand factor in hemodialysis patients., Nihon Toseki Igakkai Zasshi, 25(4), 361-367, 1992
  230. Antihypertensive effect of intravenous administration of nicardipine hydrochloride in patients with severe hypertension during hemodialysis., Nihon Toseki Igakkai Zasshi, 25(8), 893-896, 1992
  231. Recurrent hyperkalemia in the course of rheumatoid arthritis. A case report., Jpn J Nephrol, 33(8), 811-816, 1991
  232. Current status of reduced-intensity stem cell transplantation; Survey in the Kinki area, Rinsho Ketsueki, 44(6), 407-413, 2003
  233. A meeting report: 16th International HLA and Immunogenetics Workshop, MHC, 20(1), 57-61, 2013
  234. Role of HLA compatibility in unrelated cord blood transplantation, MHC, 20(2), 101-107, 2013
  235. POSITIVE CONVERSION OF ANTI-HBS AND ANTI-HBC ANTIBODIES TRANSFERRED TO A PEDATRIC PATIENT FROM BLOOD TRANSFUSION DONORS: A CASE STUDY, Journal of the Japan Society of Blood Transfusion, 60(4), 533-538, 2014
  236. A systematic approach to organ-specific complications after allogeneic hematopoietic cell transplantation, Rinsho Ketsueki, 55(10), 2125-2135, 2014
  237. Hematopoietic cell transplantation in Japan: Nationwide Survey 2013, Rinsho Ketsueki, 55(12), 2381-2399, 2014
  238. Selection of hematopoietic stem cell source, 57(4), 723-729, 200804
  239. Case report: A case of acute abdomen as an atypical manifestation of disseminated varicella-zoster virus infection, 65(12), 1005-1008, 201111
  240. Imatinib-resistant BCR-ABL Mutants, 66(11), 2587-2593, 201111
  241. Immunoregulatory activities of immunodulatory drugs (IMiDs), 242(13), 1111-1115, 20120929
  242. Hematopoietic cell transplantation crossing the HLA barrier, 45(11), 516-519, 201310
  243. Long-term Feto-Maternal Microchimerism : Nature's Hidden Clue for Alternative Donor Hematopoietic Cell Transplantation?, Int J Hematol, 76(3), 229-237, 20021001
  244. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ATL, 50, 253-262, 20030101

Invited Lecture, Oral Presentation, Poster Presentation

  1. Recent advancement in stem cell transplantation for casualties of nuclear disaster., Tatsuo Ichinohe, 15th International Congress of Radiation Research, 2015/05/27, With Invitation, English
  2. Analysis of radiation-induced responses during early embryonic development of zebrafish., Honjo Y, Kamiya K, Ichinohe T., 15th International Congress of Radiation Research, 2015/05/27, Without Invitation, Japanese
  3. Total-body Irradiation Is Widely Heterogenous Depending on the Anatomical Site., Kumi Oshima, Masahiro Kenjo, Yasushi Nagata, Tatsuo Ichinohe., 20th Annual Congress of Asia-Pacific Blood and Marrow Transplantation Group, 2015/11/01, Without Invitation, Japanese
  4. Comprehensive T-Cell Receptor Repertoire Analysis Using Deep Sequencing and Single Cell Cloning Reveals Extreme Oligoclonality of Ex Vivo Expanded Cytomegalovirus-Reactive Cytotoxic T-Cells., Takahiko Miyama, Takakazu Kawase, Kazutaka Kitaura, Ren Chishaki, Masashi Shibata, Kumi Oshima, Hiroshi Hamana, Hiroyuki Kishi, Kiyotaka Kuzushima, Hiroh Saji, Ryuji Suzuki, Tatsuo Ichinohe., 57th Annual Meeting of the American Society of Hematology, 2015/12/05, Without Invitation, English
  5. Vitamin K2 Supports Hematopoiesis through Acting on Bone Marrow Mesenchymal Stromal/Stem Cells, Aya Fujishiro, Yasuo Miura, Masaki Iwasa, Sumie Fujii, Akihiro Tamura, Atsushi Sato, Asumi Yokota, Noriko Sugino, Hideyo Hirai, Akira Ando, Tatsuo Ichinohe, Taira Maekawa., 57th Annual Meeting of the American Society of Hematology, 2015/12/05, Without Invitation, English
  6. Impact of Unbalanced Translocation Der(1;7)(q10;p10) and -7/Del(7q) on the Prognostic Value after Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes: A Nationwide Retrospective Study., Hidehiro Itonaga, Kazunari Aoki, Jun Aoki, Ken Ishiyama, Takayuki Ishikawa, Kazuteru Ohashi, Takahiro Fukuda, Yukiyasu Ozawa, Naoki Kobayashi, Naoyuki Uchida, Tetsuya Eto, Minoko Takanashi, Tatsuo Ichinohe, Yoshiko Atsuta, Yasushi Miyazaki., 57th Annual Meeting of the American Society of Hematology, 2015/12/06, Without Invitation, English
  7. All-Trans Retinoic Acid and Interferon-Alpha Increase CD38 Expression on Adult T-Cell Leukemia Cells and Sensitize Them to T Cells Bearing Anti-CD38 Chimeric Antigen Receptors., Keichiro Mihara, Tetsumi Yoshida, Seiko Ishida, Yoshifumi Takei, Akira Kitanaka, Kazuya Shimoda, Kazuhiro Morishita, Yoshihiro Takihara, Tatsuo Ichinohe., 57th Annual Meeting of the American Society of Hematology, 2015/12/07, Without Invitation, English
  8. Bortezomib Attenuates Adhesion of B Cell Precursor Acture Lymphoblastic Lleukemia Cells to Bone Marrow Mesenchymal Stromal/Stem Cells Via Regulating SPARC Expression., Masaki Iwasa, Yasuo Miura, Aya Fujishiro, Sumie Fujii, Noriko Sugino, Satoshi Yoshioka, Akihiro Tamura, Atsushi Sato, Asumi Yokota, Katsuyuki Kito, Akira Ando, Hideyo Hirai, Akifumi Takaori-Kondo, Tatsuo Ichinohe, Taira Maekawa., 57th Annual Meeting of the American Society of Hematology, 2015/12/07, Without Invitation, English
  9. Donor Cell-Derived Hematologic Malignancy: A Survey of Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation., Motohiro Kato, Takuya Yamashita, Ritsuro Suzuki, Kimikazu Matsumoto, Hisakazu Nishimori, Satoshi Takahashi, Koji Iwato, Chiaki Nakaseko, Tadakazu Kondo, Kazunori Imada, Fumihiko Kimura, Tatsuo Ichinohe, Yoshiko Hashii, Koji Kato, Yoshiko Atsuta, Shuichi Taniguchi, Takahiro Fukuda., 57th Annual Meeting of the American Society of Hematology, 2015/12/07, Without Invitation, English
  10. Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with allogeneic Stem Cell Transplantation., Michiko Kida, Kensuke Usuki, Naoyuki Uchida, Takahiro Fukuda, Koji Iwato, Ken-ichi Matsuoka, Tetsuya Eto, Tatsuo Ichinohe, Yoshiko Atsuta, Minoko Takanashi, Akiyoshi Takami, Yasushi Miyazaki, Shingo Yano, Ken Ishiyama., 57th Annual Meeting of the American Society of Hematology, 2015/12/07, Without Invitation, English
  11. Halving time of BCR-ABL1 mRNA calculated by RQ-PCR seems to be a useful tool in CML treatment by TKI., Hideo Tanaka, Kaori Kihara, Jun Imagawa, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/16, Without Invitation, Japanese
  12. Quantitative tracing of T-cell diversity using deep sequencing in a recipient of allogeneic HCT., Kumi Oshima, Kazutaka Kitaura, Takahiko Miyama, Takakazu Kawase, Tomoko Inoue, Seiko Ishida, Kyohei Yamada, Naoya Yamasaki, Tadasuke Awaya, Moe Okuno, Tetsumi Yoshida, Seiji Saito, Yoshiaki Kuroda, Sayaka Sugihara, Jun Imagawa, Shinya Katsutani, Keichiro Mihara, Teruhisa Fujii, Ryuji Suzuki, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/16, Without Invitation, Japanese
  13. Investigator-initiated clinical trial of rituximab for thrombotic thrombocytopenic purpura., Yoshitaka Miyakawa, Kazunori Imada, Tatsuo Ichinohe, Yusuke Yamane, Kenji Nishio, Takayuki Abe, Yoshihiro Fujimura, Masanori Matsumoto, Shinichiro Okamoto., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/16, Without Invitation, Japanese
  14. Tandem autologous vs. autologous/allogeneic transplantation for myeloma – Propensity score analysis., Koji Kawamura, Takashi Ikeda, Shotaro Hagiwara, Takehiko Mori, Atsushi Shinagawa, Kaichi Nishiwaki, Kazuteru Ohashi, Shiro Kubonishi, Tatsuo Ichinohe, Koji Kato, Yasuo Morishima, Yoshiko Atsuta, Kazutaka Sunami, Yoshinobu Kanda., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  15. Graft-versus-host disease after syngeneic hematopoietic stem cell transplantation., Tetsuya Nishida, Yasushi Onishi, Takeshi Kobayashi, Takehiko Mori, Naoki Shirafuji, Heiwa Kanamori, Yasuhiko Miyazaki, Tatsuo Ichinohe, Yoshiko Atsuta, Makoto Murata., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  16. Patterns of immunoglobulin gene rearrangement may predict prognosis of diffuse large B-cell lymphoma., Tetsumi Yoshida, Keichiro Mihara, Tomohiko Taki, Yoshihiro Takihara, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  17. Comprehensive analysis of CMV-specific T-cell repertoire by deep sequencing and single cell cloning., Takahiko Miyama, Takakazu Kawase, Kazutaka Kitaura, Ren Chishaki, Masashi Shibata, Kumi Oshima, Hiroshi Hamana, Hiroyuki Kishi, Kiyotaka Kuzushima, Hiroh Saji, Ryuji Suzuki, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  18. Clinical outcome of allo-HSCT for relapsed ATLL after chemotherapy: the JCHCT ATL-WG study., Hiroshi Fujiwara, Shigeo Fuji, Atsushi Wake, Koji Kato, Yoshifusa Takatsuka, Takahiro Fukuda, Jun Tagichi, Naoyuki Uchida, Toshihiro Miyamoto, Michihiro Hidaka, Yasuhiko Miyazaki, Takeaki Tomoyose, Tokiko Nagamura, Yasuo Moroshima, Tatsuo Ichinohe, Yoshiko Atsuta, Atae Utsunomiya., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  19. Donor cell-derived hematologyic malignancy after allogeneic hematopoietic stem cell transplantation., Motohiro Kato, Takuya Yamashita, Ritsuro Suzuki, Kimikazu Matsumoto, Hisakazu Nishimori, Satoshi Takahashi, Koji Iwato, Chiaki Nakaseko, Tatuso Ichinohe, Yoshiko Atsuta, Shuichi Taniguchi, Takahiro Fukuda., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/18, Without Invitation, Japanese
  20. The current status of prophylaxis in adult patients with hemophilia: an instituteon observantion study., Seji Saito, Naoya Yamasaki, Teruhisa Fujii, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  21. CBT versus matched sibling BMT or PBSCT in 50 years older; analysis of Donor/Source WG of the JSHCT., Takaaki Konuma, Nabuhiro Tsukada, Junya Kanda, Naoyuki Uchida, Yuju Ohno, Shigesaburo Miyakoshi, Heiwa Kanamori, Michihiro Hidaka, Toru Sakura, Makoto Onizuka, Naoki Kobayashi, Masashi Sawa, Tetsuya Eto, Yoshiko Matsuhashi, Koji Kato, Tatsuo Ichinohe, Yoshiko Atsuta, Koichi Miyamuta., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  22. Bacillus cereus infection associated with pneumatosis intestinelis in a patient with acute leukemia., Mai Nishina, Kumi Oshima, Kyohei Yamada, Tadasuke Awaya, Jun Imagawa, Norihumi Shigemoto, Hiroki Ohge, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  23. A survey of ESBL-producing Enterobacteriaceae in a single institute hematology unit., Tomoko Inoue, Kumi Oshima, Norifumi Shigemoto, Hiroki Ohge, Tatsuo Ichinohe., 2015/10/17, Without Invitation, Japanese
  24. Effects of low-dose irradiation on the function of human bone marrow mesenchymal stromal/stem cells., Aya Fujishiro, Yasuo Miura, Masaki Iwasa, Akihiro Tamura, Atsushi Sato, Asumi Yokota, Hideyo Hirai, Akira Ando, Taira Maekawa, Tatsuo Ichinohe., The 77th Annual Meeting of the Japanese Society of Hematology, 2015/10/17, Without Invitation, Japanese
  25. Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma Harboring a 8q24/ MYC Rearrangement: A Retrospective Registry Study from the Japan Society for Hematopoietic Cell Transplantation., Tsutomu Takahashi, Ritsuro Suzuki, Koji Izutsu, Hideyuki Nakazawa, Sachiko Suzuki, Junya Kuroda, Katsuji Kaida, Hitoshi Ohno, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Junji Suzumiya., 58th Annual Meeting of the American Society of Hematology, 2016/12/03, Without Invitation, English
  26. Late Adherent Subpopulation in Umbilical Cord Blood Has the Same Characteristics and Hematopoiesis-Supporting Capacity As Mesenchymal Stromal/Stem Cells., Satoshi Yoshioka, Yasuo Miura, Masaki Iwasa, Aya Fujishiro, Noriko Sugino, Sumie Fujii, Yoko Nakagawa, Atsushi Sato, Asumi Yokota, Hideyo Hirai, Tatsuo Ichinohe, Akifumi Kondo Takaori, Taira Maekawa., 58th Annual Meeting of the American Society of Hematology, 2016/12/04, Without Invitation, English
  27. Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Patients 50 Years or Older., Koji Kawamura, Shinichi Kako, Shuichi Mizuta, Ken Ishiyama, Jun Aoki, Shingo Yano, Takahiro Fukuda, Naoyuki Uchida, Yukiyasu Ozawa, Tetsuya Eto, Koji Iwato, Tatsuo Ichinohe, Yoshiko Atsuta, Yoshinobu Kanda., 2016/12/04, Without Invitation, English
  28. Hideki Nakasone, Kimikazu Yakushijin, Shigeo Fuji, Makoto Onizuka, Akihito Shinohara, Kazuteru Ohashi, Koichi Miyamura, Naoyuki Uchida, Minoko Takanashi, Tatsuo Ichinohe, Yoshiko Atsuta, Takahiro Fukuda, Masao Ogata., Impact of Total Body Irradiation on Successful Neutrophil Engraftment in Unrelated Bone Marrow or Cord Blood Transplantation., 58th Annual Meeting of the American Society of Hematology, 2016/12/04, Without Invitation, English
  29. Impact of the Presence of HLA 1-Locus Mismatch and the Use of Thymoglobulin in Unrelated Bone Marrow Transplantation., Koji Kawamura, Junya Kanda, Shigeo Fuji, Kosuke Yoshioka, Yukiyasu Ozawa, Takahiro Fukuda, Naoyuki Uchida, Koji Iwato, Tatsuo Ichinohe, Yoshiko Atsuta, Yoshinobu Kanda., 58th Annual Meeting of the American Society of Hematology, 2016/12/05, Without Invitation, English
  30. T Cells Bearing Anti-CD19-and/or Anti-CD38-Chimeric Antigen Receptors Effectively Abrogate Primary Double-Hit Lymphoma Cells., Keichiro Mihara, Tetsumi Yoshida, Yoshifumi Takei, Naomi Sasaki, Yoshihiro Takihara, Tatsuo Ichinohe., 58th Annual Meeting of the American Society of Hematology, 2016/12/05, Without Invitation, English
  31. Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia Harboring t(7;l l)(p15;p15)., Kaito Harada, Noriko Doki, Jun Aoki, Jinichi Mori, Shinichiro Machida, Yuho Najima, Naoyuki Uchida, Takahiro Fukuda, Heiwa Kanamori, Hiroyasu Ogawa, Tatsuo Ichinohe, Yoshiko Atsuta, Shingo Yano., 58th Annual Meeting of the American Society of Hematology, 2016/12/05, Without Invitation, English
  32. Impact of the presence of HLA 1-locus mismatch and the use of ATG in unrelated transplantation., Koji Kawamura, Junya Kanda, Shigeo Fiji, Kosuke Yoshioka, Takahiro Fukuda, Yukiyasu Ozawa, Koji Iwato, Naoyuki Uchida, Tetsuya Eto, Tatsuo Ichinohe, Yoshiko Atsuta, Yoshinobu Kanda., 2016/10/13, Without Invitation, Japanese
  33. Human bone marrow mesenchymal stromal/stem cells modulate IMiDs-induced differentiation of HSPCs., Sumie Fuji, Yasuo Miura, Masaki Iwasa, Aya Fujishiro, Noriko Sugino, Atsushi Sato, Asumi Yokota, Hideyo, Hirai, Akifumi Takaori-Kondo, Tatsuo Ichinohe, Taira Maekawa., 2016/10/13, Without Invitation, Japanese
  34. Pomalidomide + low-dose dexamethasone for Japanese with relapsed/refractory multiple myeloma (RRMM)., Shinichiro Okamoto, Shotaro Hagiwara, Kosei Matsue, Shinsuke Iida, Kazutaka Sunami, Takuya Komeno, Kenshi Suzuki, Kiyoshi Ando, Masafumi Taniwaki, Kensei Tobinai, Takaaki Chou, Hitomi Kaneko, Hiromi Iwasaki, Chie Uemura, Hiromi Tamakoshi, Mohammed H. Zaki, Thomas Doerr, Yoshiaki Kuroda, Tatsuo Ichinohe., 2016/10/13, Without Invitation, Japanese
  35. Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GVHD: a JSHCT analysis., Makoto Murata, Kazuhiro, Ikegame, Yoshihisa Morishita, Hiroyasu Ogawa, Hirohisa Nakamae, Takashi Ikeda, Tetsuya Nishida, Masami Inoue, Tetsuya Eto, Tatsuo Ichinohe, Yoshiko Atsuta, Takanori Teshima., 2016/10/13, Without Invitation, Japanese
  36. An exploratory research for the GVHD prophylaxis after conventional CBT for adult leukemia., Seitaro Terakura, Makoto Murata, Rika Sakai, Takuhiro Yamaguchi, Satoshi Takahashi, Naoyuki Uchida, Yasushi Onishi, Kazuteru Ohashi, Yukiyasu Ozawa, Heiwa Kanamori, Hiroki Yamaguchi, Tatsuo Ichinohe, Minoko Takanashi, Yoshiko Atsuta, Takanori Teshima., 2016/10/13, Without Invitation, Japanese
  37. Impact of der (1;7) (q10;p10) and -7/del (7q) on the prognostic value after allo-HSCT in MDS., Hidehiro Itonaga, Ken Ishiyama, Jun Aoki, Kazunari Aoki, Takayuki Ishikawa, Kazuteru Ohashi, Takahiro Fukuda, Yukiyasu Ozawa, Naoki Kobayashi, Naoyuki Uchida, Tetsuya Eto, Minoko Takanashi, Tatsuo Ichinohe, Yoshiko Atsuta, Yasushi Miyazaki., 2016/10/14, Without Invitation, Japanese
  38. Clinical implications of t(11;14), t(4;14), and del17p in myeloma patients treated with ASCT., Hiroyuki Takamatsu, Takeshi Yamashita, Shingo Kurahashi, Takayuki Saitoh, Tadakazu Kondo, Takeshi Maeda, Koji Kawamura, Toshihiro Miyamoto, Sumihisa Honda, Tatsuo Ichinohe, Yoshiko Atsuta, Kazutaka Sunami., 2016/10/14, Without Invitation, Japanese
  39. Impact of TBI on engraftment and non-relapse mortality in unrelated HCT., Hideki Nakasone, Kimikazu Yakushijin, Shigeo Fuji, Makoto Onizuka, Akihito Shinohara, Takeshi Hagino, Koichi Miyamura, Naoyuki Uchida, Minoko Takanashi, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Atsuta, Masao Ogata., 2016/10/14, Without Invitation, Japanese
  40. Comparison of reduced-intensity conditioning with fludarabine/busulfan and fludarabine/melphalan., Koji Kawamura, Shinichi Kato, Shuichi Mizuta, Ken Ishiyama, Jun Aoki, Shingo Yano, Takahiro Fukuda, Naoyuki Uchida, Koji Iwato, Tetsuya Eto, Ken-Ichi Matsuoka, Tatsuo Ichinohe, Yoshiko Atsuta, Yoshinobu Kanda., 2016/10/14, Without Invitation, Japanese
  41. Autologous HCT for APL during second CR before and after the introduction of arsenic trioxide., Masamitsu Yanada, Shingo Yano, Heiwa Kanamori, Moritaka Gotoh, Nobuhiko Emi, Kyoko Watakabe, Mineo Kurokawa, Akinori Nishikawa, Yoshiko Atsuta, Tatsuo Ichinohe, Akiyoshi Takami., 2016/10/14, Without Invitation, Japanese
  42. Outcomes and risk factors with stem cell transplantation for therapy-related myeloid neoplasms., Michiko Kida, Kensuke Usuki, Naoyuki Uchida, Takahiro Fukuda, Koji Iwato, Ken-Ichi Matsuoka, Tetsuya Eto, Tatsuo Ichinohe, Yoshiko Atsuta, Minoko Takanashi, Akiyoshi Takami, Yasushi Miyazaki, Shingo Yano, Ken Ishiyawa., 2016/10/14, Without Invitation, Japanese
  43. Stem cell memory T-cells are a reservoir of functional T-cells highly shared among individuals., Takahiko Miyama, Takakaza Kawase, Kazutaka Kitaura, Ren Chishaki, Masashi Shibata, Kumi Oshima, Hiroshi Hamana, Hiroyuki Kishi, Kiyotaka Kuzushima, Hiroh Saji, Ryuji Suzuki, Tatsuo Ichinohe., 2016/10/14, Without Invitation, Japanese
  44. Thrombocytopenia in pregnancy: Analysis of 92 pregnancies in 70 women., Sayaka Sugihara, Tatsuo Ichinohe., 2016/10/14, Without Invitation, Japanese
  45. Vitamin K2 supports hematopoiesis through acting on human bone marrow mesenchymal stromal/stem cells., Aya Fujishiro, Yasuo Miura, Masaki Iwasa, Sumie Fujii, Noriko Sugino, Atsushi Sato, Asumi Yokota, Hideyo Hirai, Akira Andoh, Kaoru Tohyama, Tatsuo Ichinohe, Taira Maekawa., 2016/10/14, Without Invitation, Japanese
  46. Role of RIC allogeneic HCT in older patients with AML, Satoshi Yamasaki, Akihiro Hirakawa, Jun Aoki, Naoyuki Uchida, Takahiro Fukuda, Hiroyasu Ogawa, Kazuteru Ohashi, Tadakazu Kondo, Tetsuya Eto, Heiwa Kanamori, Hirokazu Okumura, Koji Iwato, Tatsuo Ichinohe, Junya Kanda, Makoto Onizuka, Yachiyo Kuwatsuka, Masamitsu Yanada, Yoshiko Atsuta, Akiyoshi Takami, Shingo Yano., 2016/10/15, Without Invitation, Japanese
  47. Anti-CD38 chimeric antigen receptor T cells effectively abrogate primary double-hit lymphoma cells., Keichiro Mihara, Tetsumi Yoshida, Naomi Sasaki, Yoshihiro Takihara, Tatsuo Ichinohe., 2016/10/15, Without Invitation, Japanese
  48. Next-generation sequencing-based immunobioinformatics: toward a comprehensive understanding of the human immune system., Tatsuo Ichinohe, The 50th Congress of Japanese Association of Germfree Life and Gnotobiology and The 39th Congress of the Society for Microbial Ecology and Disease, 2017/06/09, With Invitation, English, Tokyo
  49. Significance of plasma citrulline levels as a predictive biomarker for intestinal mucosal injury during the early phase of hematopoietic cell transplantation., Noriyasu Fukushima, Satoshi Tomiyasu, Yoshinori Uji, Masako Yokoo, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Eizaburo Sueoka, Tatsuo Ichinohe, Shinya Kimura, 2017/06/08, Without Invitation, English, Tokyo
  50. Landscape of immune reconstitution after allogeneic hematopoietic cell transplantation is superdominated by distinct T cell populations bearing T-cell receptor clonotypes shared among different individuals., Takahiko Miyama, Takakazu Kawase, Yasuko Honjo, Kazutaka Kitaura, Tadasu Shin-I, Ryuji Suzuki and Tatsuo Ichinohe, Takakazu Kawase, Yasuko Honjo, Kazutaka Kitaura, Tadasu Shin-I, Ryuji Suzuki and Tatsuo Ichinohe, 59th Annual Meeting of the American Society of Hematology, 2017/12/11, Without Invitation, English, Atlanta, GA, U.S.A.
  51. Human bone marrow mesenchymal stromal/stem cell-derived extracellular vesicles ameliorate graft-versus-host diseases-related manifestations., Sumie Fujii, Yasuo Miura, Aya Fujishiro, Takero Shindo, Yutaka Shimazu, Hideyo Hirai, Akifymi-Takaori-Kondo, Tatsuo Ichinohe, Taira Maekawa, 59th Annual Meeting of the American Society of Hematology, 2017/12/11, Without Invitation, English, Atlanta, GA, U.S.A.
  52. Safety and efficacy of once-daily intravenous busulfan in allogeneic transplantation: a matched-pair analysis., Shinichi Kako, Shin-ichiro Fujiwara, Miki Sato, Shun-ichi Kimura, Hideki Nakasone, Kazuteru Ohashi, Michihiro Hidaka, Tetsuo Maeda, Takanobu Morishita, Ritsuro Suzuki, Takahiro Fukuda, Tatsuo Ichinohe, Mio Kurata Yoshiko Atsuta, Yoshinobu Kanda, 59th Annual Meeting of the American Society of Hematology, 2017/12/10, Without Invitation, English, Atlanta, GA, U.S.A.
  53. Melphalan dose in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity fludarabine and melphalan., Kaito Harada, Shinichiro Machida, Masamitsu Yanada, Heiwa Kanamori, Makoto Onizuka, Yukiyasu Ozawa, Hikaru Kobayashi, Masashi Sawa, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Shingo Yano, 59th Annual Meeting of the American Society of Hematology, 2017/12/10, Without Invitation, English, Atlanta, GA, U.S.A.
  54. Rearrangement can predicts prognosis of diffuse large B-cell lymphoma in association with CDC25A overexpression., Yoshida T, Mihara K, Ohtaki M, Ohno Y, Takihara Y, Shiroma N, Arihiro K, Takei Y, Sasaki N, Ichinohe T, 2018 ASH Meeting on Lymphoma Biology, 2018/08/02, Without Invitation, English, Chantilly, VA, U.S.A.
  55. Prediction of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation using a matching learning algorithm., Arai Y, Kondo T, Fuse K, Shibasaki Y, Masuko M, Sugita J, Teshima T, Uchida N, Fukuda T, Ohashi T, Ozawa Y, Ichinohe T, Kanda Y, Atsuta Y, 60th Annual Meeting of the American Society of Hematology, 2018/12/01, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  56. Characterization of novel major histocompatibility complex genes in zebrafish., Honjo Y, Ichinohe T, Nanopore community meeting 2018, 2018/11/28, Without Invitation, English, San Fransisco, CA, USA
  57. Risk factors and predictive scoring system for post-transplant lymphoproliferative disorder after haeamtopoietic stem cell transplantation., Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, Mori T, Kanda Y, Kondo T, Tanaka J, Ichinohe T, Atsuta Y, Ogata M, Suzuki R, 60th Annual Meeting of the American Society of Hematology, 2018/12/01, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  58. Impact of homozygous conserved extended HLA haplotypes on cord blood transplantation: implications for induced pluripotent stem cell banking and transplantation., Morishima Y, Morishima S, Murata M, Arima N, Uchida N, Ohno Y, takahashi S, Matsuhashi Y, Onizuka M, Eto T, Atsuta Y, Fukuda T, Ichinohe T, Kato S, Kanda J, 60th Annual Meeting of the American Society of Hematology, 2018/12/01, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  59. Reduced-intensity allogeneic HSCT for children and adolescents/young adults with CML. A study from the Adult and Pediatric CML Workinng Group of the Japan Society for Hematopoietic Cell Transplantation., Shimada H, Tanizawa A, Kondo T, Muramatsu H, Yasui M, Tojo A, Nagamura-Inoue T, Eto T, Igarashi A, Kanamori H, Sato M, Noguchi M, Ichinohe T, Inoue M, Kato K, Atsuta Y, Ohashi K, 60th Annual Meeting of the American Society of Hematology, 2018/12/02, Without Invitation, English, American Society of Hematology,, San Diego CA, U.S.A.
  60. Efficacy and safety of autologous stem cell transplantation in elderly patients with multiple myeloma in the era of novel agents., Mizuno S, Kawamura K, Hanamura I, Sunami K, Mori T, Nakamura F, Iida S, Nakazawa H, Makita M, Kako S, Sawa M, Ueda Y, Takahashi H, Kanda Y, Ichinohe T, Atsuta Y, Takamatsu H, 60th Annual Meeting of the American Society of Hematology, 2018/12/02, Without Invitation, English, American Society of Hematology,, San Diego CA, U.S.A.
  61. Epidemiology of second allogenneic hematopoietic stem cell transplantation for patients with relapsed myelodysplastic syndrome., Shimomura Y, Hara M, Tachibana T, Ohashi K, Ozawa Y, Eto T, Uchida N, Mori T, Kanda J, Ichinohe T, Atsuta Y, Ichikawa T, Ishiyama K, 60th Annual Meeting of the American Society of Hematology, 2018/12/02, Without Invitation, Japanese, American Society of Hematology, an Diego CA, U.S.A.
  62. Effect of haplotype matching on outcomes after adult single cord blood transplantation., Kanda J, Kawase T, Tanaka H, Uchida N, Nagafuji K, Matsuhashi Y, Ohno Y, Onizuka M, Tanaka J, Ichinohe T, Atsuta Y., 60th Annual Meeting of the American Society of Hematology,, 2018/12/02, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  63. Mixed chimerism and secondary engraftment failure in allogeneic transplantation for aplastic anemia., Kako S, Yamazaki H, Ohashi K, Ozawa Y, Ota S, Kanda Y, Maeda T, Kato J, Ishiyama K, Matsuoka K, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, 60th Annual Meeting of the American Society of Hematology, 2018/12/03, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  64. Who is the best donor for the second transplant?: HLA discrepancy between graft and host rather than that graft and first donor may impact the second transplant outcome from the JSHCT., Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Hirokawa M, Ichinohe T, Atsuta Y, Kanda Y, Kanda J, 60th Annual Meeting of the American Society of Hematology, 2018/12/03, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  65. Comparable survival outcomes of haploidentical stem cell transplantation and unrelated bone marrow transplantation., Sugita J, Atsuta Y, Kurata M, Nakamae H, Kurita N, Ishiyama K, Shiratori S, Fukuda T, Ohashi K, Ozawa Y, Kanda J, Ichinohe T, Teshima T, 60th Annual Meeting of the American Society of Hematology, 2018/12/03, Without Invitation, English, American Society of Hematology, San Diego CA, U.S.A.
  66. Would bone marrow be associated with superior outcomes compared with peripheral blood for male patients with female donors in HLA-matched related transplantation?, Nakasone H, Kawamura K, Yakushijin K, Shinohara A, Kanamori H, Ohashi K, Fukuda T, Uchida N, Nakamae H, Kanda J, Ichinohe T, Atsuta Y, Inamoto Y, Seo S, Kimura F, Ogata M, 60th Annual Meeting of the American Society of Hematology, 2018/12/03, Without Invitation, Japanese, American Society of Hematology, San Diego CA, U.S.A.
  67. Effects of ionizing radiation on zebrafish early embryogenesis., Honjo Y, Ichinohe T, 3rd International symposium of the Network-type Joint Usage/Research Center for Radiation Dissaster Medical Science,, 2019/01/13, Without Invitation, English, Fukushima
  68. Trends in survival of AML patients undergoing related and unrelated HCT during the past two decades., Masamitsu Yanada, Masayoshi Masuko, Jinichi Mori, Jun Aoki, Shohei Mizuno, Takahiro Fukuda, Kazuhiko Kakihana, Yukiyasu Ozawa, Shuichi Ota, Heiwa Kanamori, Takehiko Mori, Hirohisa Nakamae, Tetsuya Eto, Souichi Shiratori, Tetsuo Maeda, Koji Iwato, Tatsuo Ichinohe, Yoshinobu Kanda, Junji Tanaka, Yoshiko Atsuta2, Shingo Yano, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  69. Effect of allogeneic stem cell transplantation for patients with minimally differentiated AML., Satoshi Yamasaki, Jun Aoki, Jinichi Mori, Kaito Harada, Masashi Sawa, Naoyuki Uchida, Kazuteru Ohashi, Takahiro Fukuda, Shiro Koh, Heiwa Kanamori, Hiroyasu Ogawa, Hirokazu Okumura, Tatsuo Ichinohe, Yoshinobu Kanda, Junji Tanaka, Yoshiko Atsuta, Masamitsu Yanada, Shingo Yano, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  70. Mixed chimerism and secondary engraftment failure in allogeneic transplantation for aplastic anemia., Shinichi Kako, Hirohito Yamazaki, Kazuteru Ohashi, Takahiko Sato, Shuichi Ota, Yoshinobu Kanda, Tetsuo Maeda, Jun Kato, Ken Ishiyama, Ken-Ichi Matsuoka, Toshihiro Miyamoto, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Takehiko Mori, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  71. Human BM-MSC derived extracellular vesicles modulate hematopoietic cells in GVHD mice., Fujii Sumie, Yasuo Miura, Aya Fujishiro, Takero Shindo, Yutaka Shimazu, Hideyo Hirai, Akifumi Takaori-Kondo, Tatsuo Ichinohe, Taira Maekawa, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  72. Comprehensive T cell receptor (TCR) repertoire analysis of new T cell subsets with naive phenotype., Kisa Tanabe, Takakazu Kawase, Kazutaka Kitaura, Takahiko Miyama, Misaki Kobayashi, Mayu Sato, Takayuki Oda, Aoi Sakamoto, Kiyoto Tanaka, Kiyotaka Kuzushima, Kazuo Yamashita, Tadasu Shin-I, Ryuji Suzuki, Tatsuo Ichinohe, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  73. Impact of PB vs BM on NRM and survival in female to male HGT from HLA-matched related donors., Hideki Nakasone, Koji Kawamura, Kimikazu Yakushijin, Akihito Shinohara, Heiwa Kanamori, Kazuteru Ohashi, Takahiro Fukuda, Naoyuki Uchida, Hirohisa Nakamae, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Yoshihiro Inamoto, Sachiko Seo, Fumihiko Kimurai, Masao Ogata, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  74. Molecular cloning and characterization of endoglin gene in zebrafish., Kosuke Takano, Yasuko Honjo, Tatsuo Ichinohe, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  75. Daratumumab-resistant 17p-deleted myeloma with extramedullary lesions successfully treated with DCEP., Kayo Toishigawa, Hisao Nagoshi, Keita Fujino, Taro Edahiro, Takahiko Miyama, Takehiko Morioka, Takakazu Kawase, Keichiro Mihara, Noriyasu Fukushima, Tatsuo Ichinohe, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/12, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  76. GVHD free, relapse free survival in allogeneic transplantation for adult T cell leukemia/lymphoma., Hiroyuki Muranushi, Takero Shindo, Masakatsu Hishizawa, Masahito Tokunaga, Atsushi Wake, Nobuaki Nakano, Tetsuya Eto, Michihiro Hidaka, Kaname Miyashita, Toshihiro Miyamoto, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Koji Kato, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/13, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  77. HTLV-1-associated indolent CD8+ T cell proliferative disorder: is it a distinct clinical entity?, Taro Edahiro, Kayo Toishigawa, Takehiko Morioka, Takahiko Miyama, Hisao Nagoshi, Takakazu Kawase, Hiromi Nakagawa, Mitsunori Noma, Kazutaka Kitaura, Ryuji Suzuki, Keichiro Mihara, Noriyasu Fukushima, Tatsuo Ichinohe, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/13, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  78. Elotuzumab-based combination therapy for multiple myeloma relapsed after autologous transplantation., Hisao Nagoshi, Jun Imagawa, Keichiro Mihara, Keita Fujino, Taro Edahiro, Kayo Toishigawa, Takahiko Miyama, Takehiko Morioka, Takakazu Kawase, Noriyasu Fukushima, Tatsuo Ichinohe, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/13, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  79. Prognostic factors for adult single CBT among European and Japanese transplant cohorts., Junya Kanda, Hiromi Hayashi, Annalisa Ruggeri, Fumihiko Kimura, Fernanda Volt, Satoshi Takahashi, Myriam Labopin, Shinichi Kako, Karina Tozatto-Maio, Shingo Yano, Guillermo Sanz, Naoyuki Uchida, Maria Teresa Van Lint, Seiko Kato, Mohamad Mohty, Noel Milpied, Heiwa Kanamori, Jorge Sierra, Yuju Ohno, Riccardo Saccardi, Takahiro Fukuda, Tatsuo Ichinohe, Minoko Takanashi, Shinichiro Okamoto, Arnon Nagler, Yoshiko Atsuta, Eliane Gluckman, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/14, Without Invitation, Japanese, Japanese Society of Hematology, Osaka
  80. Involvement of impaired ribosome biogenesis in leukemia development., Satoru Shinriki, Akinori Kanai, Akiko Nagamachi, Tatsuo Ichinohe, Toshiya Inaba, Hirotaka Matsui, The 80th Annual Meeting of the Japanese Society of Hematology, 2018/10/14, Without Invitation, Japanese, Japanese Society of Hematology, Osaka

External Funds

Acceptance Results of Competitive Funds

  1. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation), 2015/04/01, 2016/03/31
  2. KAKENHI, 2014, 2016
  3. KAKENHI, Functional expression of HLA class Ib molecules in bone marrow-derived mesenchymal stromal cells and its implication for cellular immunotherapy, 2010, 2012
  4. KAKENHI, Development of effective hematopoietic stem cell transplantation/cellular immunotherapy for adult T-cell leukemia, 2005, 2009
  5. KAKENHI, 2000, 2001
  6. Health and Labour Sciences Research Grants, 2014/05/29, 2015/03/31
  7. KAKENHI, 2015, 2016
  8. KAKENHI, The potential role of HLA-G on transplantation immunity - examination of increasing recent reports -, 2010, 2013
  9. KAKENHI, 2015
  10. KAKENHI(Grant-in-Aid for Scientific Research (B)), 2017, 2019
  11. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation) , 2017/04/01, 2018/03/31
  12. Practical Research Project for Allergic Diseases and Immunology (Research on Technology of Medical Transplantation) , 2017/04/01, 2018/03/31
  13. KAKENHI, Elucidation of structural basis of MHC-crossreactive T cell receptors : new insights into adaptive immunity, 2018, 2019

Social Activities

History as Committee Members

  1. Director, 2014/03, 2016/03, Japan Society for Hematopoietic Cell Transplantation (JSHCT)
  2. Director, 2016/03, 2018/02, Japan Society for Hematopoietic Cell Transplantation (JSHCT)
  3. Director, 2015/06, 2017/06, Japanese Data Center for Hematopoietic Cell Transplantation (JDCHCT)
  4. Appointed Director, 2014/09, 2016/10, Japasene Society for Histocompatibility and Immunogenetics (JSHI)
  5. Director, 2014/01, 2017/06, Japanese Association of Germfree Life and Gnotobiology (JAGG)

Organizing Academic Conferences, etc.

  1. 48th Congress of Japanese Association of Germlife and Gnotobiology (JAGG), President, 2015/01, 2015/01
  2. The Joint Congress of the 19th International Sumposium on Gnotobiology, President, 2017/06, 2017/06
  3. The 26th Annual Meeting of the Japan Society for Histocompatibility and Immunogenetics, President, 2017/10, 2017/10